K
Karl-Heinz Kuck
Researcher at University of Hamburg
Publications - 814
Citations - 50630
Karl-Heinz Kuck is an academic researcher from University of Hamburg. The author has contributed to research in topics: Catheter ablation & Atrial fibrillation. The author has an hindex of 94, co-authored 776 publications receiving 44368 citations. Previous affiliations of Karl-Heinz Kuck include St George's Hospital.
Papers
More filters
Journal Article
Richtlinien für die Durchführung invasiver elektrophysiologischer Untersuchungen
M. Block,Martin Borggrefe,L. Goedel-Meinen,Stefan H. Hohnloser,D. Kalusche,Karl-Heinz Kuck,Thomas Meinertz,M. Oeff,H. Pitschner,H. J. Volkmann +9 more
Journal ArticleDOI
Secondary prevention of sudden death.
Riccardo Cappato,Karl-Heinz Kuck +1 more
TL;DR: Four prospective randomized controlled trials investigating the comparative efficacy of antiarrhythmic drug therapy versus ICDs in patients with previosly documented sustained ventricular arrhythmias have been recently concluded.
Journal ArticleDOI
Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study.
Joost Daemen,Felix Mahfoud,Felix Mahfoud,Karl-Heinz Kuck,Bert Andersson,Michael Böhm,Tobias Graf,Horst Sievert,Philipp Kahlert,Mano Iyer,Thomas Zeller +10 more
TL;DR: This single-arm study represents the largest cohort of patients treated with endovascular ultrasound renal denervation to date and appears safe and resulted in sustained reductions in both office BP and 24-h ambulatory BP through 12 months.
Journal ArticleDOI
Delivery of a Bioresorbable Vascular Scaffold to Complex Lesions
TL;DR: A case of successful delivery and implantation of two overlapping Absorb® BVS to a complex lesion in the left anterior descending artery is described, demonstrating the feasibility of delivering Absorb‐BVS to more complex lesions than practiced so far in the setting of clinical trials.
Journal ArticleDOI
Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial
Atul Verma,David E. Haines,Lucas V.A. Boersma,Nitesh Sood,Andrea Natale,Francis E. Marchlinski,Hugh Calkins,Prashanthan Sanders,Douglas L. Packer,Karl-Heinz Kuck,Gerhard Hindricks,Birce Onal,Jeffrey Cerkvenik,Hiroshi Terada,David B. Delurgio +14 more
TL;DR: PULSED as discussed by the authors is a prospective, global, multicenter, nonrandomized, paired single-arm study in which patients with paroxysmal or persistent symptomatic atrial fibrillation (AF) refractory to class I or III antiarrhythmic drugs were treated with pulsed field ablation.